Ocrelizumab

Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Ocrelizumab and local guidelines before prescribing.

Anti-CD20 monoclonal antibody

Mechanism

Anti-CD20 monoclonal antibody.

Uses

Relapsing and primary progressive multiple sclerosis.

Dosing

No dose is given in the chapters. See the BNF.

Side effects

Infusion reactions, infections, hypogammaglobulinaemia, malignancy risk.

Interactions

Live vaccines contraindicated.

Contraindications and cautions

Active infection, malignancy

Monitoring

Immunoglobulins, infection signs

Pregnancy and breastfeeding

Avoid

Renal and hepatic impairment

No adjustment

Overdose and reversal

Supportive

Special advice

Hepatitis B screening before starting; vaccinate beforehand.

More from the textbook: uses, cautions and other points
Where it is discussed in the book